BackSatellos Bioscience Common Stock Overview

Satellos Bioscience Common Stock Accounts Payable

Satellos Bioscience Common Stock's accounts payable is $0.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00
↓ 100.00% YoYΔ $-1.89M vs prior year quarter

Peer average

Loading

Satellos Bioscience Common Stock Accounts Payable History

Loading

Satellos Bioscience Common Stock vs. peers: Accounts Payable Comparison

Loading

Satellos Bioscience Common Stock Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Satellos Bioscience Common Stock (MSLE) FAQ

As of the most recent data (March 2026), MSLE shows a accounts payable of $0. That compares with $1.9M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MSLE's accounts payable is now $0 (was $1.9M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Satellos Bioscience Common Stock is outperforming or lagging.

Tracking MSLE's accounts payable over time shows whether Satellos Bioscience Common Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $1.9M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Satellos Bioscience Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $0) with ownership activity and broader fundamentals.